Latest article
Researchers develop complete being pregnant care administration plan amongst Chinese language pregnant girls kind...
University of Science and Technology of ChinaThe research team, led by Prof. WENG Jianping of the University of Science and Technology in China (USTC)...
Lilly’s tirzepatide beats Ozempic in head-to-head kind 2 diabetes trial
Eli Lilly announced that its investigated GIP and GLP-1 inhibitor tirzepatide has demonstrated superiority over Novo Nordisk's Ozempic in a Phase III study.The SURPASS-2...